No significant correlation was found between the clinical (gender, ECOG, perforated/obstructive acute abdomen, tumor stage, lung or liver metastasis, primary tumor site) and pathological (histological type, LNR) features and KRAS mutation status. The gene discussed is KRAS; the disease is neoplasm.